azathioprine has been researched along with Plasma Cell Tumor in 12 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A current southeastern cancer study group protocol for the treatment of multiple myeloma involves induction with BCNU, cyclophosphamide, and prednisone (BCP) and maintenance with either melphalan and prednisone (MP), prednisone, Adriamycin, imuran, and vincristine (PAIV), or delayed treatment of relapsed cases following induction." | 7.66 | Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model. ( Cohen, HJ; Durant, JR; Ghanta, VK; Hiramoto, RN; Silberman, HR, 1981) |
| "A current southeastern cancer study group protocol for the treatment of multiple myeloma involves induction with BCNU, cyclophosphamide, and prednisone (BCP) and maintenance with either melphalan and prednisone (MP), prednisone, Adriamycin, imuran, and vincristine (PAIV), or delayed treatment of relapsed cases following induction." | 3.66 | Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model. ( Cohen, HJ; Durant, JR; Ghanta, VK; Hiramoto, RN; Silberman, HR, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghanta, VK | 1 |
| Cohen, HJ | 1 |
| Silberman, HR | 1 |
| Durant, JR | 1 |
| Hiramoto, RN | 1 |
| Sterioff, S | 1 |
| Rios, CN | 1 |
| Zachary, JB | 1 |
| Williams, GM | 1 |
| Lovisetto, P | 1 |
| Manachino, D | 1 |
| Biarese, V | 1 |
| Marchi, L | 1 |
| Andrione, P | 1 |
| Shen, SY | 1 |
| Weir, MR | 1 |
| Litkowski, L | 1 |
| Anthony, R | 1 |
| Welik, R | 1 |
| Kosenko, A | 1 |
| Light, PD | 1 |
| Dagher, FJ | 1 |
| Sadler, JH | 1 |
| Kuster, G | 1 |
| Woods, JE | 1 |
| Anderson, CF | 1 |
| Weiland, LH | 1 |
| Wilkowske, CJ | 1 |
| Schlossberg, M | 1 |
| Hollander, VP | 1 |
| Neuberg, R | 1 |
| Melli, G | 1 |
| Penn, I | 1 |
| Hammond, W | 1 |
| Brettschneider, L | 1 |
| Starzl, TE | 1 |
| Mandel, MA | 1 |
| DeCosse, JJ | 1 |
| Kessel, M | 1 |
| Gerhartz, H | 1 |
| Taguchi, J | 1 |
| Taguchi, T | 1 |
| Krueger, GR | 1 |
| Malmgren, RA | 1 |
| Berard, CW | 1 |
1 review available for azathioprine and Plasma Cell Tumor
| Article | Year |
|---|---|
[Blood hypereosinophilias. IV. Symptomatic hypereosinophilias: connective tissue diseases, neoplasms, blood diseases, various causes].
Topics: Aged; Asthma; Azathioprine; Connective Tissue Diseases; Cortisone; Eosinophilia; Female; Hematologic | 1985 |
1 trial available for azathioprine and Plasma Cell Tumor
| Article | Year |
|---|---|
Therapeutic results in paraproteinemic diseases and immunoreactions during treatment with cytostatic agents.
Topics: Adrenal Cortex Hormones; Azathioprine; Blood Protein Disorders; Blood Proteins; Bone Marrow Examinat | 1965 |
10 other studies available for azathioprine and Plasma Cell Tumor
| Article | Year |
|---|---|
Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model.
Topics: Animals; Antineoplastic Agents; Azathioprine; Doxorubicin; Drug Therapy, Combination; Female; Humans | 1981 |
Neoplasia in kidney transplant recipients.
Topics: Adult; Azathioprine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Female; Huma | 1975 |
Enzyme-linked immunosorbent assay for serum renal tubular antigen in kidney transplant patients.
Topics: Animals; Antibodies, Monoclonal; Antigens; Azathioprine; Cell Line; Enzyme-Linked Immunosorbent Assa | 1985 |
Plasma cell lymphoma after renal transplantation.
Topics: Adult; Age Factors; Antacids; Antilymphocyte Serum; Azathioprine; Hepatitis A; Humans; Injections, S | 1972 |
Imuran-induced regression of plasma cell tumor MOPC-315.
Topics: Animals; Azathioprine; Blood Proteins; Cyclophosphamide; Immunosuppressive Agents; Mercaptopurine; M | 1973 |
Immunosuppression and plasmocytoma of the cervix.
Topics: Adult; Azathioprine; Diabetes Complications; Female; Furosemide; Humans; Immunosuppression Therapy; | 1974 |
[Immunosuppressive therapy].
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Animals; Autoimmune Diseases; Azathioprine; | 1970 |
Malignant lymphomas in transplantation patients.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Brain Neoplasms; Female; Humans; Immunosuppre | 1969 |
The effects of heterologous antithymocyte sera in mice. V. Enhancement of plasma cell tumor induction.
Topics: Animals; Antilymphocyte Serum; Ascitic Fluid; Azathioprine; Cyclophosphamide; Immunoelectrophoresis; | 1972 |
Malignant lymphomas and plasmacytosis in mice under prolonged immunosuppression and persistent antigenic stimulation.
Topics: Animals; Antigens; Antilymphocyte Serum; Atrophy; Azathioprine; Female; Freund's Adjuvant; Glomerulo | 1971 |